Further modification on phenyl acetic acid based quinolines as liver X receptor modulators

被引：32

作者：

Hu, Baihua

Jetter, James

Kaufman, David

Singhaus, Robert

Bernotas, Ronald

Unwalla, Rayomand

Quinet, Elaine

Savio, Dawn

Halpern, Anita

Basso, Michael

Keith, James

Clerin, Valerie

Chen, Liang

Liu, Qiang-Yuan

Feingold, Irene

Huselton, Christine

Azam, Farooq

Goos-Nilsson, Annika

Wilhelmsson, Anna

Nambi, Ponnal

Wrobel, Jay

机构：

[1] Wyeth Pharmaceut, Chem & Screening Sci, Collegeville, PA 19426 USA

[2] Wyeth Pharmaceut, Cardiovasc & Metab Disorders, Collegeville, PA USA

[3] Wyeth Pharmaceut, Bio Transformat & Disposit, Collegeville, PA USA

[4] Karobio, Huddinge, Sweden

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2007年 / 15卷 / 10期

关键词：

liver X receptor (LXR); LXR agonists; quinoline; phenyl acetic acid;

D O I：

10.1016/j.bmc.2007.03.013

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A series of phenyl acetic acid based quinolines was prepared as LXR modulators. An SAR study in which the C-3 and C-8 positions of the quinoline core were varied led to the identification of two potent LXR agonists 23 and 27. Both compounds displayed good binding affinity for LXR beta and LXR alpha, and increased expression of ABCAl in THP-1 cells. These two compounds also had desirable pharmacokinetic profiles in mice and displayed in vivo efficacy in a 12-week Apo E knockout mouse lesion model. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：3321 / 3333

页数：13

共 17 条

[1] A NOVEL-APPROACH TO DUAL-ACTING THROMBOXANE RECEPTOR ANTAGONIST AND SYNTHASE INHIBITORS BASED ON THE LINK OF 1,3-DIOXANE-THROMBOXANE RECEPTOR ANTAGONISTS AND 1,3-DIOXANE-THROMBOXANE SYNTHASE INHIBITORS
ACKERLEY, N
BREWSTER, AG
BROWN, GR
CLARKE, DS
FOUBISTER, AJ
GRIFFIN, SJ
HUDSON, JA
SMITHERS, MJ
WHITTAMORE, PRO
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (10) : 1608 - 1628
[2] An update on non-steroidal liver X receptor agonists and their potential use in the treatment of atherosclerosis
Bennett, D. Jonathan
D Brown, Lindsay
Cooke, Andrew J.
Edwards, Andrew S.
[J]. EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (12) : 1673 - 1699
[3] BIAGI G, 1988, FARMACO, V43, P597
[4] BRADLEY MN, 2005, DRUG DISCOV TODAY, P97
[5] Key role of dietary fats in coronary heart disease under progressive urbanization and nutritional transition
Bulliyya, G
[J]. ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION, 2000, 9 (04) : 289 - 297
[6] Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines
Collins, JL
Fivush, AM
Watson, MA
Galardi, CM
Lewis, MC
Moore, LB
Parks, DJ
Wilson, JG
Tippin, TK
Binz, JG
Plunket, KD
Morgan, DG
Beaudet, EJ
Whitney, KD
Kliewer, SA
Willson, TM
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (10) : 1963 - 1966
[7] Collins JL, 2004, CURR OPIN DRUG DISC, V7, P692
[8] Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis
Hu, Baihua
Collini, Michael
Unwalla, Rayomand
Miller, Christopher
Singhaus, Robert
Quinet, Elaine
Savio, Dawn
Halpern, Anita
Basso, Michael
Keith, James
Clerin, Valerie
Chen, Liang
Resmini, Christine
Liu, Qiang-Yuan
Feingold, Irene
Huselton, Christine
Azam, Farooq
Farnegardh, Mathias
Enroth, Cristofer
Bonn, Tomas
Goos-Nilsson, Annika
Wilhelmsson, Anna
Nambi, Ponnal
Wrobel, Jay
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (21) : 6151 - 6154
[9] Jaye Michael, 2003, Curr Opin Investig Drugs, V4, P1053
[10] Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) α -: PPARα fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expression
Lawrence, JW
Li, Y
Chen, SY
DeLuca, JG
Berger, JP
Umbenhauer, DR
Moller, DE
Zhou, GC
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) : 31521 - 31527

← 1 2 →